237 related articles for article (PubMed ID: 17090210)
1. Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis.
Huang JT; Leweke FM; Oxley D; Wang L; Harris N; Koethe D; Gerth CW; Nolden BM; Gross S; Schreiber D; Reed B; Bahn S
PLoS Med; 2006 Nov; 3(11):e428. PubMed ID: 17090210
[TBL] [Abstract][Full Text] [Related]
2. Comparison between clinical diagnosis and CSF biomarkers of Alzheimer disease in elderly patients with late onset psychosis: Helsinki Old Age Psychosis Study (HOPS).
Seppälä TT; Louhija UM; Appelberg B; Herukka SK; Juva K
Am J Geriatr Psychiatry; 2014 Sep; 22(9):908-16. PubMed ID: 23597931
[TBL] [Abstract][Full Text] [Related]
3. [Serum of transthyretin as a treatment-responsive biomarker for schizophrenia].
Nakagawa N; Yao H; Nakahara T; Inomata S; Hashimoto K; Kuroki T
Brain Nerve; 2013 Sep; 65(9):1093-9. PubMed ID: 24018746
[TBL] [Abstract][Full Text] [Related]
4. CSF metabolic and proteomic profiles in patients prodromal for psychosis.
Huang JT; Leweke FM; Tsang TM; Koethe D; Kranaster L; Gerth CW; Gross S; Schreiber D; Ruhrmann S; Schultze-Lutter F; Klosterkötter J; Holmes E; Bahn S
PLoS One; 2007 Aug; 2(8):e756. PubMed ID: 17712404
[TBL] [Abstract][Full Text] [Related]
5. Obsessive-compulsive and panic symptoms in patients with first-admission psychosis.
Craig T; Hwang MY; Bromet EJ
Am J Psychiatry; 2002 Apr; 159(4):592-8. PubMed ID: 11925297
[TBL] [Abstract][Full Text] [Related]
6. Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects.
Castaño EM; Roher AE; Esh CL; Kokjohn TA; Beach T
Neurol Res; 2006 Mar; 28(2):155-63. PubMed ID: 16551433
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies in blood and cerebrospinal fluids of patients with psychosis.
Sokol DK; O'Brien RS; Wagenknecht DR; Rao T; McIntyre JA
J Neuroimmunol; 2007 Oct; 190(1-2):151-6. PubMed ID: 17868908
[TBL] [Abstract][Full Text] [Related]
8. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
Novikova SI; He F; Cutrufello NJ; Lidow MS
Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel biomarker candidate, a 4.8-kDa peptide fragment from a neurosecretory protein VGF precursor, by proteomic analysis of cerebrospinal fluid from children with acute encephalopathy using SELDI-TOF-MS.
Asano T; Koizumi S; Takagi A; Hatori T; Kuwabara K; Fujino O; Fukunaga Y
BMC Neurol; 2011 Aug; 11():101. PubMed ID: 21838886
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential CSF biomarkers in ALS.
Pasinetti GM; Ungar LH; Lange DJ; Yemul S; Deng H; Yuan X; Brown RH; Cudkowicz ME; Newhall K; Peskind E; Marcus S; Ho L
Neurology; 2006 Apr; 66(8):1218-22. PubMed ID: 16481598
[TBL] [Abstract][Full Text] [Related]
11. Sensory gating deficits, pattern completion, and disturbed fronto-limbic balance, a model for description of hallucinations and delusions in schizophrenia.
Javanbakht A
Med Hypotheses; 2006; 67(5):1173-84. PubMed ID: 16824690
[TBL] [Abstract][Full Text] [Related]
12. Progressive brain changes in children and adolescents with first-episode psychosis.
Arango C; Rapado-Castro M; Reig S; Castro-Fornieles J; González-Pinto A; Otero S; Baeza I; Moreno C; Graell M; Janssen J; Parellada M; Moreno D; Bargalló N; Desco M
Arch Gen Psychiatry; 2012 Jan; 69(1):16-26. PubMed ID: 22213785
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis.
Ranganathan S; Williams E; Ganchev P; Gopalakrishnan V; Lacomis D; Urbinelli L; Newhall K; Cudkowicz ME; Brown RH; Bowser R
J Neurochem; 2005 Dec; 95(5):1461-71. PubMed ID: 16313519
[TBL] [Abstract][Full Text] [Related]
14. Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid.
Vafadar-Isfahani B; Ball G; Coveney C; Lemetre C; Boocock D; Minthon L; Hansson O; Miles AK; Janciauskiene SM; Warden D; Smith AD; Wilcock G; Kalsheker N; Rees R; Matharoo-Ball B; Morgan K
J Alzheimers Dis; 2012; 28(3):625-36. PubMed ID: 22045497
[TBL] [Abstract][Full Text] [Related]
15. A novel peptidomics approach to detect markers of Alzheimer's disease in cerebrospinal fluid.
Wijte D; McDonnell LA; Balog CI; Bossers K; Deelder AM; Swaab DF; Verhaagen J; Mayboroda OA
Methods; 2012 Apr; 56(4):500-7. PubMed ID: 22465281
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
[TBL] [Abstract][Full Text] [Related]
17. Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme.
Schuhmann MU; Zucht HD; Nassimi R; Heine G; Schneekloth CG; Stuerenburg HJ; Selle H
Eur J Surg Oncol; 2010 Feb; 36(2):201-7. PubMed ID: 19674866
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid findings in patients with psychotic symptoms-a retrospective analysis.
Rattay TW; Martin P; Vittore D; Hengel H; Cebi I; Tünnerhoff J; Stefanou MI; Hoffmann JF; von der Ehe K; Klaus J; Vonderschmitt J; Herrmann ML; Bombach P; Al Barazi H; Zeltner L; Richter J; Hesse K; Eckstein KN; Klingberg S; Wildgruber D
Sci Rep; 2021 Mar; 11(1):7169. PubMed ID: 33785807
[TBL] [Abstract][Full Text] [Related]
19. An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease.
Hölttä M; Minthon L; Hansson O; Holmén-Larsson J; Pike I; Ward M; Kuhn K; Rüetschi U; Zetterberg H; Blennow K; Gobom J
J Proteome Res; 2015 Feb; 14(2):654-63. PubMed ID: 25490617
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human cleaved N-CAM and association with schizophrenia.
Vawter MP; Usen N; Thatcher L; Ladenheim B; Zhang P; VanderPutten DM; Conant K; Herman MM; van Kammen DP; Sedvall G; Garver DL; Freed WJ
Exp Neurol; 2001 Nov; 172(1):29-46. PubMed ID: 11681838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
